Geron Corporation
General ticker "GERN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.2B (TTM average)
Geron Corporation does not follow the US Stock Market performance with the rate: -2.0%.
Estimated limits based on current volatility of 3.5%: low 1.29$, high 1.39$
Factors to consider:
- Total employees count: 229 (+62.4%) as of 2024
- Top business risk factors: Regulatory and compliance, Trade policy changes, Litigation risks, Cybersecurity threats, ERP implementation risks
- Current price 49.6% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.61$, 5.68$]
- 2025-12-31 to 2026-12-31 estimated range: [2.60$, 5.69$]
Financial Metrics affecting the GERN estimates:
- Positive: with PPE of -12.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -9.76 <= 0.04
- Positive: 42.53 < Shareholder equity ratio, % of 47.21 <= 64.17
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term GERN quotes
Long-term GERN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.60MM | $0.24MM | $76.99MM |
| Operating Expenses | $139.15MM | $194.18MM | $250.73MM |
| Operating Income | $-138.55MM | $-193.94MM | $-173.73MM |
| Non-Operating Income | $-3.35MM | $9.82MM | $-0.84MM |
| Interest Expense | $6.88MM | $8.31MM | $18.50MM |
| R&D Expense | $95.52MM | $125.05MM | $103.74MM |
| Income(Loss) | $-141.90MM | $-184.13MM | $-174.57MM |
| Profit(Loss)* | $-141.90MM | $-184.13MM | $-174.57MM |
| Stockholders Equity | $80.00MM | $247.95MM | $280.32MM |
| Inventory | $0.00MM | $0.00MM | $38.71MM |
| Assets | $190.57MM | $394.08MM | $593.78MM |
| Operating Cash Flow | $-127.38MM | $-167.74MM | $-218.62MM |
| Capital expenditure | $0.43MM | $0.83MM | $0.68MM |
| Investing Cash Flow | $62.07MM | $-180.32MM | $-106.00MM |
| Financing Cash Flow | $87.26MM | $362.02MM | $334.37MM |
| Earnings Per Share** | $-0.37 | $-0.32 | $-0.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.